Open AccessRHAMNETIN IS A BETTER INHIBITOR OF SARS-COV-2 2’-O-METHYLTRANSFERASE THAN DOLUTEGRAVIR: A COMPUTATIONAL PREDICTION
Author(s) -
Adekunle Babajide Rowaiye,
Angus Nnamdi Oli,
Olukemi Onuh,
Nkoli W Emeter,
Doofan Bur,
Oluwaseun A. Obideyi,
Oluyomi Cornelius Dayisi,
Jude N. Akpa,
Lovelyn Birah,
Edward E. Omaka,
Frances Otibhor Iseghohi,
Akinbobola Peace Otitoju,
Philip F. Uzor,
Jude Nnaemeka Okoyeh
Publication year - 2022
Publication title -
african journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.386
H-Index - 11
eISSN - 2505-0419
pISSN - 2006-0165
DOI - 10.21010/ajid.v16i2.9
Subject(s) - dolutegravir , covid-19 , medicine , pharmacology , virology , human immunodeficiency virus (hiv) , viral load , antiretroviral therapy , disease , infectious disease (medical specialty)
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom